Loading...
Response to Lapatinib-Capecitabine combination in a young patient with recurrent HER2-positive breast cancer refractory to two lines of therapy with anti-HER2 drugs
HER2-positive breast cancer is an aggressive tumour that affects approximately one in five breast cancer women. Clinical studies have shown that HER2-positive cancer have different characteristics from other mammary tumors: a more rapid progression of the disease, an earlier age of onset (women of c...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AboutScience Srl
2018-10-01
|
| Serier: | AboutOpen |
| Fag: | |
| Online adgang: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/135 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|